Mycotopia Therapies, Inc. Overview
Pro stress-test →Data integrity issue: Mycotopia Therapies Inc. (OTC: TPIA) underwent a corporate transition to AIBiotics, Inc. (ticker AIBT) during 2022-2024. The company's current status, business operations, and strategic direction as of June 2026 cannot be accurately determined from available sources.
Strategic Profile
Pro stress-test →Historical profile (2021-2022): Mycotopia was a psychedelics-focused biopharma company pursuing natural and biosynthetic psilocybin development, supply agreements with Havn Life Sciences, and planned mergers with Ei.Ventures. However, this profile is obsolete due to corporate restructuring.
Competitive Landscape
Pro stress-test →Historical competitors included Compass Pathways, MindMed, and Atai Life Sciences in psychedelics space. Current competitive positioning unknown due to corporate restructuring.
Industry Context
Mycotopia Therapies, Inc. operates in Unknown (formerly Psychedelics Development; now potentially AI/Robotics Wellness).
Key facts
Headquarters: Miami, US